Skip to Main Content

Paper Details

Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Proc Natl Acad Sci U S A
17
2017
Author NameAffiliation
Kelly ReganComprehensive Cancer Center, The Ohio State University
Albert de la ChapelleComprehensive Cancer Center, The Ohio State University
Ann-Kathrin EisfeldComprehensive Cancer Center, The Ohio State University
  • 1 - 3

Datasets

Release 1.2